The Quinidine/digoxin phenomenon concomitant use of quinidine and digoxin may result in significantly elevated serum digoxin levels

Visual Material Registration

The Quinidine/digoxin phenomenon concomitant use of quinidine and digoxin may result in significantly elevated serum digoxin levels

Status

Published

on 14 Jun 2007

Year of Creation

1980

Searle Pharmaceuticals, Inc

Registration Number

TX0001003872

on 14 Jun 2007

The U.S. Copyright record (Registration Number: TX0001003872) dated 14 Jun 2007, pertains to an electronic file (eService) titled "The Quinidine/digoxin phenomenon concomitant use of quinidine and digoxin may result in significantly elevated serum digoxin levels" created in 1980. The copyright holder is Searle Pharmaceuticals, Inc, known for their creative contributions in visual material registration. For any inquiries concerning this copyrighted material, kindly reach out to Searle Pharmaceuticals, Inc.

Searle Pharmaceuticals, Inc

Application Details

Registration Number

TX0001003872

Registration Date

6/14/2007

Year of Creation

1980

Agency Marc Code

DLC-CO

Record Status

New

Corporate Author

Searle Pharmaceuticals, Inc

Corporate Authors

Inc Searle Pharmaceuticals

Notes

Material Matter Claimed Note: New Matter: "textual material."

Notes

Material Matter Claimed Note: New Matter: "textual material."

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.